<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    jbm
   </journal-id>
   <journal-title-group>
    <journal-title>
     Journal of Biosciences and Medicines
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2327-5081
   </issn>
   <issn publication-format="print">
    2327-509X
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/jbm.2025.134013
   </article-id>
   <article-id pub-id-type="publisher-id">
    jbm-141930
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Switch-On Time for Act Gene Expression and Switch-Off Time of the 16S rRNA Gene for Optimization Production of Actinorhodin Antibiotic by Streptomyces coelicolor strain ATCC 10147
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ihsan Ali
      </surname>
      <given-names>
       Mahasneh
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Islam M.
      </surname>
      <given-names>
       Ahmady
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mona
      </surname>
      <given-names>
       Mahfood
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Noora
      </surname>
      <given-names>
       Algatham
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mai
      </surname>
      <given-names>
       Awad
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Iman
      </surname>
      <given-names>
       Hazaymeh
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aDepartment of Applied Biology-Biotechnology Program, Faculty of Science, University of Sharjah, Sharjah, UAE
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aDepartment of Biological Sciences, Al-Bayt University, Mafraq, Jordan
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     31
    </day> 
    <month>
     03
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    13
   </volume> 
   <issue>
    04
   </issue>
   <fpage>
    141
   </fpage>
   <lpage>
    151
   </lpage>
   <history>
    <date date-type="received">
     <day>
      6,
     </day>
     <month>
      March
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      12,
     </day>
     <month>
      March
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      12,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    The aim of the study was to determine the switch-on time for Act gene expression and switch-off time of the 16S rRNA gene for optimization production of the actinorhodin antibiotic by Streptomyces coelicolor strain ATCC 10147. The full sequence of 1804 bp of the 16SrRNA gene of the S. coelicolor strain ATCC 10147 was determined, and its phylogenetic tree is given with 99.9% homology to the closest sister strains, S. coelicolor strains M1154 and A3(2). The expression switch-on time of the Act gene was determined to be after 34 h of growth, whereas the switch-off time of 16S rRNA was determined to be at 120 h of growth by the addition of chloramphenicol, which blocks the RNA enzyme peptidyl transferase center, which is located at the lower tips (acceptor ends) of the A- and P-site tRNAs, where it binds to the residues A2451 and A2452 in the 23S rRNA (component of 50S) and prevents the attachment of aminoacyl transferase to the ribosomal subunit, which inhibits peptide bond formation. The optimum growth conditions for actinorhodin production were determined in liquid growth as nutrient broth as a C-source (1% starch), N-source (K
    <sub>2</sub>NO
    <sub>3</sub>), P-source (K
    <sub>2</sub>PO
    <sub>4</sub>), Fe-source (FeCl
    <sub>3</sub>-EDTA), shaking speed (200 rpm), pH 7.0, 28˚C, and aerobic conditions. The extracellular and intracellular actinorhodin reached 165 mg
    <sup>−</sup>
    <sup>1</sup> and 88 mg
    <sup>−</sup>
    <sup>1</sup>, respectively. The optimum growth of the strain on solid media was on nutrient agar plus 1% starch. For production of the antibiotic droplets on the colony’s surface, the strain was cultured on potato dextrose agar (PDA) for 5 days before several droplets (3 - 5) appeared on the top of each colony. The actinorhodin activity was tested against the international MRSA control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain. The inhibition zones were 21 mm and 24 mm for the MRSA control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain, respectively. The MIC of the actinorhodin antibiotic was 2.0 ug/ml and 4.0 ug/ml for the MRSA control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain. The results are novel on the ON/OFF switching of interplay regulation of gene expression for optimization of actinorhodin antibiotic production by S. coelicolor strain ATCC 10147. The results also provide evidence of optimization of actinorhodin antibiotic production using cheap starch as a C-source to produce a highly effective antibiotic against MRSA and the MAR pathogens. 
   </abstract>
   <kwd-group> 
    <kwd>
     Sequencing of 16 SrRNA Genes
    </kwd> 
    <kwd>
      Actinorhodin Antibiotic Production
    </kwd> 
    <kwd>
      S. coelicolor strain ATCC 10147
    </kwd> 
    <kwd>
      Multi-Resistant Pathogens
    </kwd> 
    <kwd>
      Phylogenetic Tree
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Currently, there is a worldwide urgent need to produce a new generation of antibiotics against the increasing global crisis of multi-antibiotic resistant (MAR) pathogens, known as superbugs, which are the causative agents of nosocomial infections in worldwide hospitals. For instance, after the World Health Organization (WHO) published a list of bacteria for which new antibiotics were urgently needed in 2017 and this year, 2025, WHO determined the production of antibiotics against multi-resistant MR bacteria is among the top priorities for this year, 2025 (<xref ref-type="bibr" rid="scirp.141930-https://www.who.int">
     https://www.who.int
    </xref>) <xref ref-type="bibr" rid="scirp.141930-1">
     [1]
    </xref>. The most recent Global Antimicrobial Surveillance System (GLASS) by the World Health Organization (WHO) reveals a significant prevalence of AMR among a population of 500,000 individuals diagnosed with bacterial illnesses in 22 different countries <xref ref-type="bibr" rid="scirp.141930-2">
     [2]
    </xref>. Furthermore, the most comprehensive global estimates of the MAR have been reported as posing a major threat to human health around the world on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations <xref ref-type="bibr" rid="scirp.141930-3">
     [3]
    </xref>-<xref ref-type="bibr" rid="scirp.141930-5">
     [5]
    </xref>. Multi-antibiotic resistance (MAR) is a critical global health issue driven by antibiotic misuse and overuse in various sectors, leading to the emergence of antibiotic-resistant “priority pathogens” that pose the greatest threat to human health. The biotechnological importance of Streptomyces as producers for the majority of the broad-spectrum commercial antibiotics in use today keeps them as the main natural stock for screening programs <xref ref-type="bibr" rid="scirp.141930-6">
     [6]
    </xref>-<xref ref-type="bibr" rid="scirp.141930-8">
     [8]
    </xref>. Therefore, the aim of the study was to determine the switch-on time for Act gene expression and switch-off time of the 16S rRNA gene for optimization production of actinorhodin antibiotic by Streptomyces coelicolor strain ATCC 10147.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <sec id="s2_1">
    <title>2.1. Bacterial Source</title>
    <p>Streptomyces coelicolor strain ATCC 10147 (Muller) Waksman and Henrici was imported from the American (<xref ref-type="bibr" rid="scirp.141930-https://www.atcc.org/products/10147">
      https://www.atcc.org/products/10147
     </xref>) on May 2023 with all documentations as needed for the export certificate of origin.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Growth Conditions and Characteristics</title>
    <p>For maintenance and experimental sub-culturing, Streptomyces coelicolor ATCC 10147 was grown in ATCC Medium 1877: ISP Medium 1 broth according to manufacturer instruction (HiMedia, India) and then incubated at 26˚C - 28˚C in a shaking incubator under aerobic conditions. The components of the ATCC medium, 1877 ISP Medium 1, as dissolved in 1.0 L distilled water, were tryptone (BD 211705) (5.0 gm), yeast extract (3.0 gm), and agar (if necessary) (15.0 gm). Adjust the medium for a final pH of 7.0 - 7.2 before autoclaving at 121˚C for 15 minutes. A 50% glycerol stock was prepared and stored at −80˚C for further investigation. For growth characterization and genomic DNA extraction, Streptomyces coelicolor ATCC 10147 was grown in ISP Medium 1 agar (from HiMedia, India) and incubated for 5 - 7 days at 28˚C under aerobic conditions until full growth was attained, as the aerial mycelia became abundant and medium gray whilst the vegetative mycelia were blue-gray with a blue soluble pigment.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Genomic DNA Extraction and 16S rRNA Gene Amplification</title>
    <p>Genomic DNA was extracted from 1 ml of pure bacterial culture using the Isolate II Genomic DNA kit (Bioline, BIO-52066) according to the manufacturer’s protocol. The purity and concentration of extracted genomic DNA were assessed using the NanoDrop One Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific). To amplify the 16S rRNA gene, the MicroSEQ Full Gene 16S rDNA PCR Kit (Thermo Fisher Scientific, 4349155) was used. In brief, 60 ng of genomic DNA was used in three separate PCR reactions, thereby amplifying three overlapping fragments to ensure that a high-quality and full-length gene sequence was obtained. PCR was carried out according to the following conditions: 95˚C for 10 minutes; 30 cycles of 95˚C for 30 seconds, 60˚C for 30 seconds, and 72˚C for 45 seconds, followed by a final extension at 72˚C for 10 minutes. Generated amplicons were then verified by visualizing them on a 2% agarose gel. Moreover, 5 ul of each PCR product was treated with ExoSAP-IT PCR Product Cleanup Reagent (Thermo Fisher Scientific, 78200.200.UL) according to the supplied protocol and used for sequencing.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. 16S rRNA Gene Sequencing</title>
    <p>Sequencing reactions were conducted via the MicroSEQ Full Gene 16S rDNA Sequencing Kit (Thermo Fisher Scientific, 4347484) according to the manufacturer’s protocol. In short, each of the three purified PCR products was sequenced using both their respective forward and reverse primers, resulting in six reactions. Sequencing reactions were carried out using the following conditions: 25 cycles of 96˚C for 10 seconds, 50˚C for 5 seconds, and 60˚C for 4 minutes. Sequencing reactions were then purified using the ethanol/EDTA/sodium acetate precipitation method. Afterward, capillary sequencing was carried out by the Genetic Analyzer 3500 (Applied Biosystems, Thermo Fisher Scientific, USA). Obtained forward and reverse sequences were then analyzed using the Sequencing Analysis Software 6 (Applied Biosystems, Thermo Fisher Scientific, USA) and assembled into one contiguous sequence using the CAP3 software (<xref ref-type="bibr" rid="scirp.141930-https://doua.prabi.fr/software/cap3">
      https://doua.prabi.fr/software/cap3
     </xref>). Finally, the assembled sequence was aligned to published sequences using the Basic Local Alignment Search Tool (BLAST) (<xref ref-type="bibr" rid="scirp.141930-https://blast.ncbi.nlm.nih.gov/Blast.cgi">
      https://blast.ncbi.nlm.nih.gov/Blast.cgi
     </xref>).</p>
   </sec>
   <sec id="s2_5">
    <title>2.5. Pairwise Sequence Alignment</title>
    <p>The full gene sequence of the bacterial strain extracted was aligned automatically using the BLAST tool against the gene libraries available for bacterial species in the NCBI (<xref ref-type="bibr" rid="scirp.141930-https://www.ncbi.nlm.nih.gov/">
      https://www.ncbi.nlm.nih.gov/
     </xref>), Sanger Institute (<xref ref-type="bibr" rid="scirp.141930-https://www.sanger.ac.uk/">
      https://www.sanger.ac.uk/
     </xref>), DDBJ (<xref ref-type="bibr" rid="scirp.141930-https://www.ddbj.nig.ac.jp/index-e.html">
      https://www.ddbj.nig.ac.jp/index-e.html
     </xref>), and EMBL-EBI GeneBank (<xref ref-type="bibr" rid="scirp.141930-https://www.ebi.ac.uk/">
      https://www.ebi.ac.uk/
     </xref>) databases.</p>
   </sec>
   <sec id="s2_6">
    <title>2.6. Multiple Sequence Alignment</title>
    <p>The phylogenetic analysis was constructed using the neighbor-joining tree of the isolated strain using BLAST and CLUSTAL W (1.83) available in the following international gene banks: National Center for Biotechnology Information (NCBI), International Nucleotide Sequence Databases (INSD) (DDBJ GenBank), and EMBL-EBI Bank (European Bioinformatics Institute and the European Molecular Biology Laboratory). The closely related homologous strains were identified, retrieved, and compared to the sequence of the strain extracted, using CLUSTAL W (version 3.2) available on the Biology StudyBench (<xref ref-type="bibr" rid="scirp.141930-https://www.ncbi.nlm.nih.gov/">
      https://www.ncbi.nlm.nih.gov/
     </xref>).</p>
   </sec>
   <sec id="s2_7">
    <title>2.7. Statistical Criteria for Species Identification</title>
    <p>Genotyping identification of species through sequence similarity was determined based on the international diagnostic criteria as set by the international gene banks (International Nucleotide Sequence Databases (INSD) (DDBJ GenBank), EMBL-EBI Bank (European Bioinformatics Institute and the European Molecular Biology Laboratory), and the National Center for Biotechnology Information (NCBI), where if the difference between the query and the compared strain is 1% - 1.5% (14 - 22 bp), 1.5% - 5.0% (23 - 72 bp), and 5.0% - 7.0% (72 - 98 bp), then the query strain should be given to the same species, genus, or a different genus, respectively.</p>
   </sec>
   <sec id="s2_8">
    <title>2.8. Determination of Actinorhodin Antibiotic</title>
    <p>The production of antibiotics by the present strain was determined as described earlier <xref ref-type="bibr" rid="scirp.141930-9">
      [9]
     </xref> and as follows: 10 ml of the culture broth were taken and centrifuged at 200 rpm for 10 minutes, resulting in having two portions: the supernatant (extracellular actinorhodin) and the cells pellet (cellular actinorhodin). Then, 1.0 ml of 1 N KOH was added to the supernatant, and pH was adjusted to 8.0 before extracellular actinorhodin was determined by measuring the absorption at A640 nm. For the cellular actinorhodin, it was extracted by the addition of 10 ml of 1 N KOH to the pellet, centrifuged at 2000 rpm for 10 minutes, and the pH was adjusted to 8.0 before cellular actinorhodin was determined by measuring the absorption at A640 nm. For statistical assurance, 4 replicates were used for the mean value calculation. For production of the antibiotic droplets on the surface of the colonies, the strain was cultured on potato dextrose agar (PDA) and incubated for several days.</p>
   </sec>
   <sec id="s2_9">
    <title>2.9. Antibiotic Activity of the Actinorhodin Antibiotic</title>
    <p>The antimicrobial assay for the strain antibiotics was conducted using both the inhibition zone method and the minimum inhibition concentration. The actinorhodin activity was tested against the multi-antibiotic resistant (MAR) control strain Staphylococcus aureus ATCC 25923 and the local MAR Bacillus cereus strain using the agar well diffusion method <xref ref-type="bibr" rid="scirp.141930-10">
      [10]
     </xref>. The MAR strains were grown overnight on nutrient agar plates at 37˚C before four colonies were collected by using a sterile loop and resuspended in 2 ml saline solution, vortexed to obtain a homogenous mixture. The suspension was adjusted to the 0.5 McFarland standard (~1.5 × 10<sup>8</sup> CFU/ml) and tested for antibacterial activity using agar well diffusion <xref ref-type="bibr" rid="scirp.141930-11">
      [11]
     </xref>. For statistical assurance, 4 replicates were used for the mean value calculation.</p>
    <p>The actinorhodin supernatant was collected from the grown Streptomyces coelicolor strain ATCC 10147 in 250-ml Erlenmeyer flasks that contained 150 ml of starch casein broth with supplements. The flasks were incubated for 8 days at 28˚C and 150 rpm, and cultures were later centrifuged at 10,000 rpm for 10 mins, and the cell-free supernatant was used to determine the antimicrobial activity against the MAR strains using the agar-well diffusion method on Mueller Hinton agar plates (Lab M, UK). The sterile 6 mm Whatman filter paper discs were soaked in 50 μl of the extract, and the same quantity was introduced into the bored holes on separate agar plates. The plates (4 replicates) were incubated overnight at 37˚C for 24 hours, and the inhibition zones were measured using a ruler, and the mean values were interpreted as sensitive, intermediate, and resistant according to the Clinical and Laboratory Standard Institute (CLSI) CLSI M100-Ed35 <xref ref-type="bibr" rid="scirp.141930-12">
      [12]
     </xref>.</p>
   </sec>
   <sec id="s2_10">
    <title>2.10. Determination of the Minimum Inhibition Concentration (MIC) and Biochemical Characteristics Using the VITEK-2 System</title>
    <p>The minimum inhibition concentration (MIC) and biochemical characteristics were conducted using the VITEK® SOLUTIONS—Complete automated ID/AST platform (<xref ref-type="bibr" rid="scirp.141930-https://www.biomerieux.com/">
      https://www.biomerieux.com/
     </xref>). Bacterial strains were grown overnight on nutrient agar at 37˚C. By using a sterile loop, four to five colonies were collected and resuspended in 2 ml saline solution. The density of the colonies was checked using a DensiCHEK Plus device; the reading should range from 0.58 to 0.62. The mixture was put on the cassette, and VITEK 2 Identification card Gram-Negative (ID GN) cards and VITEK 2 Identification card Gram-Positive (ID GP) cards were placed accordingly. Samples were placed in a VITEK 2 Compact device.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Morphological and Growth Characteristics</title>
    <p>The optimum growth of the strain on solid media was on nutrient agar plus 1% starch. Aerial mycelia are abundant and medium-gray. After 7 days of incubation, bacteria were grown with gray, chalky aerial mycelia and blue vegetative mycelia. Vegetative mycelia are blue-gray with a blue soluble pigment. The morphology of colony growth was typically similar to that of S. coelicolor, where it showed the actinorhodin production and then its conspicuous red color diffusion in the media after 48 h of growth. The strain was exposed to the most notable test for the S. coelicolor by the red-blue acid-base test. Thus, the colonies that become red-purple because of actinorhodin production were rapidly turned blue on fuming the colonies with ammonia, consistent with the known pH indicator properties of the compounds (<xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>).</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>Figure 1. Growth of S. coelicolor strain ATCC 10147 on nutrient agar with 1% starch (a) and in nutrient broth with 1% starch (b).</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2153125-rId28.jpeg?20250415100748" />
    </fig>
   </sec>
   <sec id="s3_2">
    <title>3.2. Phylogenetic Tree and Genotyping of the S. coelicolor strain ATCC 10147</title>
    <p>The full sequence (1804 bp) of the 16SrRNA gene of the S. coelicolor strain ATCC 10147 was determined (<xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>), and its phylogenetic tree is given with 99.9% homology to the closest sister strains, S. coelicolor strains M1154 and A3(2) (<xref ref-type="fig" rid="fig3">
      Figure 3
     </xref>).</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Expression Switch-On/Off Time of the Act Gene and Optimization Production of Actinorhodin by S. coelicolor ATCC 10147</title>
    <p>The expression switch-on time of the Act gene was determined to be 34 h, whereas the switch-off time of 16S rRNA was 120 h growth by the addition of chloramphenicol blocking the RNA enzyme peptidyl transferase center, which is located</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>Figure 2. Full sequence of the 16S rRNA gene of Streptomyces coelicolor strain ATCC 10147.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2153125-rId29.jpeg?20250415100748" />
    </fig>
    <fig id="fig3" position="float">
     <label>Figure 3</label>
     <caption>
      <title>Figure 3. Phylogenetic tree of Streptomyces coelicolor strain ATCC 10147 with the top two sister strains with 99.9% homology as constructed by the neighbor-joining method.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2153125-rId30.jpeg?20250415100748" />
    </fig>
    <p>at the lower tips (acceptor ends) of the A- and P-site tRNAs, where it binds to the residues A2451 and A2452 in the 23S rRNA (component of 50S) and prevents the attachment of aminoacyl transferase to the ribosomal subunit, which inhibits peptide bond formation (<xref ref-type="fig" rid="fig4">
      Figure 4
     </xref>). The optimum growth conditions for actinorhodin production were determined in liquid growth as: nutrient broth as C-source (1% starch), N-source (K<sub>2</sub>NO<sub>3</sub>), P-source (K<sub>2</sub>PO<sub>4</sub>), Fe-source (FeCl<sub>3</sub>-EDTA), shaking speed (200 rpm), pH 7.0, 28˚C, and aerobic conditions. The extracellular and intracellular actinorhodin reached 165 mg<sup>−</sup><sup>1</sup> and 88 mg<sup>−</sup><sup>1</sup>, respectively. The optimum growth of the strain on solid media was on nutrient agar plus 1% starch. For production of the antibiotic droplets on the colony’s surface, the strain was cultured on potato dextrose agar (PDA) for 5 days before several droplets (3 - 5) appeared on the top of each colony.</p>
   </sec>
   <sec id="s3_4">
    <title>3.4. Actinorhodin Activity against MAR and MRSA</title>
    <p>The inhibition zone activity against both the international MRSA control strain</p>
    <fig id="fig4" position="float">
     <label>Figure 4</label>
     <caption>
      <title>Figure 4. Expression switch-on time of the Act gene cluster and switch-off time of 16S rRNA gene (arrow indicate chloramphenicol addition) for optimization of actinorhodin antibiotic production by S. coelicolor strain ATCC 10147.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2153125-rId31.jpeg?20250415100748" />
    </fig>
    <p>Staphylococcus aureus ATCC 25923 and the local MAR Bacillus cereus strain was 21 mm and 24 mm for both strains, respectively. The MIC of the actinorhodin antibiotic were 2.0 µg/ml and 4.0 µg/ml for the MRSA control strain Staphylococcus aureus ATCC 25923 and local MAR Bacillus cereus strain, respectively.</p>
    <p>The actinorhodin activity was tested against the international MRSA control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain. The inhibition zones were 21 mm and 24 mm for the MR control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain, respectively. The MIC of the actinorhodin antibiotic was 2.0 ug/ml and 4.0 ug/ml for the MR control strain Staphylococcus aureus ATCC 25923 and the local MR Bacillus cereus strain.</p>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>The results are novel on the ON/OFF switching of interplay regulation of gene expression for optimization of actinorhodin antibiotic production by S. coelicolor strain ATCC 10147. The results also provide evidence of production optimization using cheap starch as a C-source to produce a highly effective antibiotic against the MRSA and MAR pathogens. The results show the synchronization induction &amp; synergistic ability to control the expression switching board of the interplay regulation for optimization of actinorhodin antibiotic production.</p>
   <p>The 16S rRNA sequence of S. coelicolor strain ATCC 10147 and its position on the phylogenetic tree revealed the closest sister strains are S. coelicolor strains M1154 and A3(2), with a homology of 99.9% in the international GeneBanks NCBI (<xref ref-type="bibr" rid="scirp.141930-www.ncbi.nlm.nih.gov">
     www.ncbi.nlm.nih.gov
    </xref>), Sanger Institute (<xref ref-type="bibr" rid="scirp.141930-http://www.sanger.ac.uk">
     http://www.sanger.ac.uk
    </xref>), DDBJ (<xref ref-type="bibr" rid="scirp.141930-http://www.ddbj.nig.ac.jp">
     http://www.ddbj.nig.ac.jp
    </xref>), and EMBL-EBI GeneBank (<xref ref-type="bibr" rid="scirp.141930-http://www.ebi.ac.uk">
     http://www.ebi.ac.uk
    </xref>) databases.</p>
   <p>The expression switch-on time of the Act gene was determined to be after 34 h of growth, whereas the switch-off time of 16S rRNA was determined to be at 120 h of growth by the addition of chloramphenicol, which blocks the RNA enzyme peptidyl transferase center, which is located at the lower tips (acceptor ends) of the A- and P-site tRNAs, where it binds to the residues A2451 and A2452 in the 23S rRNA (component of 50S) and prevents the attachment of aminoacyl transferase to the ribosomal subunit, which inhibits peptide bond formation <xref ref-type="bibr" rid="scirp.141930-13">
     [13]
    </xref>. The results also provide evidence of optimization of actinorhodin antibiotic production using cheap starch as a C-source to produce a highly effective antibiotic against MRSA and the MAR pathogens. The actinorhodin antibiotic production was similar to that reported by other strains of Streptomyces <xref ref-type="bibr" rid="scirp.141930-6">
     [6]
    </xref>-<xref ref-type="bibr" rid="scirp.141930-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.141930-14">
     [14]
    </xref>-<xref ref-type="bibr" rid="scirp.141930-16">
     [16]
    </xref>. The antibiotic potency of the actinorhodin activity was high against the MRSA control strain Staphylococcus aureus ATCC 25923 and local MAR pathogenic strains. Bacillus cereus is considered a relatively common cause of gastroenteritis worldwide as a food poisoning causative pathogen that occurs when it produces toxins, causing two types of gastrointestinal illness, such as vomiting and diarrhea. B. cereus grows in food that has been improperly stored; therefore, proper food handling, especially after cooking, will help prevent illnesses caused by this microorganism. For instance, in Canada, over 36,000 cases of foodborne illness due to B. cereus were estimated to have occurred in 2006.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>The results are novel on the ON/OFF switching of interplay regulation of gene expression for optimization of actinorhodin antibiotic production by S. coelicolor strain ATCC 10147. The results also provide evidence of production optimization using cheap starch as a C-source to produce a highly effective antibiotic against the MRSA and MAR pathogens. The results show the synchronization induction &amp; synergistic ability to control the expression switching board of the interplay regulation for optimization of actinorhodin antibiotic production.</p>
  </sec><sec id="s6">
   <title>Authors’ Contributions</title>
   <p>IAM: Conceptualization, design, phylogenetic analysis, writing up manuscript and intellectual content, project administration and supervision, investigation and methodology. IMA: Experiments, investigation, and results presentation. MM: Sequencing the 16SrRNA gene.</p>
  </sec><sec id="s7">
   <title>Funding</title>
   <p>There was no funding or financial support, as the present study did not require any type of funding support.</p>
  </sec><sec id="s8">
   <title>Availability of Data and Materials</title>
   <p>The data will be available on request.</p>
  </sec><sec id="s9">
   <title>Acknowledgements</title>
   <p>The authors would like to thank the University of Sharjah for providing the laboratory facilities and the University Hospital of Sharjah (UHS) for providing the MAR bacterial strains.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.141930-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     World Health Organization. (2025) Antimicrobial Resistance. &gt;https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance 
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ajulo, S. and Awosile, B. (2024) Global Antimicrobial Resistance and Use Surveillance System (GLASS 2022): Investigating the Relationship between Antimicrobial Resistance and Antimicrobial Consumption Data across the Participating Countries. PLOS ONE, 19, e0297921. &gt;https://doi.org/10.1371/journal.pone.0297921
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ahmed, S.K., Hussein, S., Qurbani, K., Ibrahim, R.H., Fareeq, A., Mahmood, K.A., et al. (2024) Antimicrobial Resistance: Impacts, Challenges, and Future Prospects. Journal of Medicine, Surgery, and Public Health, 2, Article ID: 100081. &gt;https://doi.org/10.1016/j.glmedi.2024.100081
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Murray, C.J.L., et al. (2022) Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. The Lancet, 399, 629-655. 
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bertagnolio, S., et al. (2024) Global Research Priorities for Antimicrobial Resistance in Human Health. The Lancet, 5, 1-14. &gt;https://www.thelancet.com/ 
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mahasneh, I.A., Al-Thani, R.F., Abuannadi, M.A. and Qandil, M.A. (2011) A Complete Sequence of the 16S rRNA Gene of a Novel Streptomyces coelicolor (AB588124) (QU66c-2002) Isolated from the Soil of Qatar. Biotechnology (Faisalabad), 10, 167-174. &gt;https://doi.org/10.3923/biotech.2011.167.174
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kumar, N.R., Balraj, T.A., Kempegowda, S.N. and Prashant, A. (2024) Multidrug-resistant Sepsis: A Critical Healthcare Challenge. Antibiotics, 13, Article 46. &gt;https://doi.org/10.3390/antibiotics13010046
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shang, Z., Sharma, V., Pai, L., Kumar, T. and Patil, S. (2025) Optimizing the Production and Efficacy of Antimicrobial Bioactive Compounds from Streptomyces kanamyceticus in Combating Multi-Drug-Resistant Pathogens. Frontiers in Cellular and Infection Microbiology, 14, Article 1500440. &gt;https://doi.org/10.3389/fcimb.2024.1500440
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ates, S., Elibol, M. and Mavituna, F. (1997) Production of Actinorhodin by Streptomyces coelicolor in Batch and Fed-Batch Cultures. Process Biochemistry, 32, 273-278. &gt;https://doi.org/10.1016/s0032-9592(96)00071-4
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Balouiri, M., Sadiki, M. and Ibnsouda, S.K. (2015) Methods for in Vitro Evaluating Antimicrobial Activity: A Review. Journal of Pharmaceutical Analysis, 6, 71-79. &gt;https://doi.org/10.1016/j.jpha.2015.11.005
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Odumosu, B.T., Buraimoh, O.M., Okeke, C.J., Ogah, J.O. and Michel, F.C. (2017) Antimicrobial Activities of the Streptomyces ceolicolor Strain AOB KF977550 Isolated from a Tropical Estuary. Journal of Taibah University for Science, 11, 836-841. &gt;https://doi.org/10.1016/j.jtusci.2017.01.006
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lewis II, J.S. (2025) CLSI M100-Ed35 Performance Standards for Antimicrobial Sus-ceptibility Testing Standards. 35th Edition. 
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Syroegin, E.A., Aleksandrova, E.V. and Polikanov, Y.S. (2022) Structural Basis for the Inability of Chloramphenicol to Inhibit Peptide Bond Formation in the Presence of A-Site Glycine. Nucleic Acids Research, 50, 7669-7679. &gt;https://doi.org/10.1093/nar/gkac548
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nitta, K., Carratore, F.D., Breitling, R., Takano, E., Putri, S.P. and Fukusaki, E. (2020) Multi-Omics Analysis of the Effect of cAMP on Actinorhodin Production in Streptomyces coelicolor. Frontiers in Bioengineering and Biotechnology, 8, Article 595552. &gt;https://doi.org/10.3389/fbioe.2020.595552
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Darby, E.M., Trampari, E., Siasat, P., Gaya, M.S., Alav, I., Webber, M.A., et al. (2023) Molecular Mechanisms of Antibiotic Resistance Revisited. Nature Reviews Microbiology, 21, 280-295. &gt;https://doi.org/10.1038/s41579-022-00820-y
    </mixed-citation>
   </ref>
   <ref id="scirp.141930-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lertcanawanichakul, M. and Sahabuddeen, T. (2023) Characterization of Streptomyces sp. KB1 and Its Cultural Optimization for Bioactive Compounds Production. PeerJ, 11, e14909. &gt;https://doi.org/10.7717/peerj.14909
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>